Business Context and Reporting Period
Company: Alphatec Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 15, 2010
Event: Entry into a Material Definitive Agreement regarding a public offering of common stock.
Key Financial Metrics
This filing details a capital raise event rather than operational financial performance. Key figures include:
- Offering Size: 16,000,000 shares of Common Stock.
- Public Offering Price: $5.00 per share.
- Share Allocation: 8,000,000 shares sold by the Company; 8,000,000 shares sold by HealthpointCapital Partners, L.P. (Selling Stockholder).
- Net Proceeds to Company: Approximately $36.8 million (after underwriting discounts, commissions, and estimated expenses).
- Proceeds to Selling Stockholder: The Company receives no proceeds from the shares sold by the Selling Stockholder.
- Over-Allotment Option: Underwriters have a 30-day option to purchase up to 1,200,000 additional shares from the Company and 1,200,000 from the Selling Stockholder.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report.
Material Changes
The primary material change is the execution of an underwriting agreement with Jefferies & Company, Inc. to facilitate the public offering. The transaction is expected to close on April 21, 2010, subject to customary closing conditions. This represents a significant increase in the Company's cash position upon closing, funded by both primary issuance and secondary sales.
Guidance, Outlook, and Risks
Outlook: The Company expects to close the offering on April 21, 2010. The proceeds are intended to strengthen the Company's financial position, though specific uses of proceeds are not detailed in this excerpt.
Risks and Contingencies:
- Closing Conditions: The transaction is subject to the satisfaction of customary closing conditions.
- Legal Disclaimers: The Underwriting Agreement contains representations and warranties made solely for the benefit of the parties to the agreement. Investors are advised not to rely on these as characterizations of the actual state of facts, as they may be subject to confidential disclosures and standards of materiality differing from those applicable to investors.
- Market Risk: The offering price is fixed at $5.00, but the final number of shares sold may vary based on the exercise of the over-allotment option.
Important Facts for Investor Verification
- Verify the final closing date and whether the over-allotment option was exercised.
- Confirm the exact net proceeds received by the Company after all expenses.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification obligations and termination provisions.
- Check subsequent filings for the specific allocation of the $36.8 million in net proceeds.
- Monitor the impact of the 8,000,000 shares sold by the Selling Stockholder on existing shareholder dilution.